tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

AKTX Stock Latest News

Akari Therapeutics Cancels Peak Bio Note and Loan
Company AnnouncementsAkari Therapeutics Cancels Peak Bio Note and Loan
8d ago
8K
AKTX
Akari Therapeutics Releases Updated Investor Presentation
PremiumCompany Announcements
Akari Therapeutics Releases Updated Investor Presentation
10d ago
8K
AKTX
Buy Rating for Akari Therapeutics: Promising ADC Innovations and Growth Potential in Oncology
PremiumRatings
Buy Rating for Akari Therapeutics: Promising ADC Innovations and Growth Potential in Oncology
14d ago
AKTX
Morning Movers: Under Armour sinks following second quarter earnings
PremiumThe Fly
Morning Movers: Under Armour sinks following second quarter earnings
21d ago
UA
AMR
Akari Therapeutics reports Q2 EPS (86c) vs. (81c) last year
PremiumThe Fly
Akari Therapeutics reports Q2 EPS (86c) vs. (81c) last year
21d ago
AKTX
Akari Therapeutics sees cash runway into 2028
PremiumThe FlyAkari Therapeutics sees cash runway into 2028
21d ago
AKTX
Akari Therapeutics releases ‘What This Means’ segment for investors
Premium
The Fly
Akari Therapeutics releases ‘What This Means’ segment for investors
1M ago
AKTX
Akari Therapeutics reiterates commitment to research on PH1
Premium
The Fly
Akari Therapeutics reiterates commitment to research on PH1
1M ago
AKTX
Akari Therapeutics ‘just getting started,’ initiated with a Buy at Maxim
PremiumThe Fly
Akari Therapeutics ‘just getting started,’ initiated with a Buy at Maxim
1M ago
AKTX
Akari Therapeutics initiated with a Buy at Maxim
PremiumThe Fly
Akari Therapeutics initiated with a Buy at Maxim
1M ago
AKTX
Akari Therapeutics Shareholders Approve Key AGM Resolutions
PremiumCompany Announcements
Akari Therapeutics Shareholders Approve Key AGM Resolutions
2M ago
8K
AKTX
Akari Therapeutics releases ‘What This Means’ segment for investors
PremiumThe Fly
Akari Therapeutics releases ‘What This Means’ segment for investors
2M ago
AKTX
Akari Therapeutics announces granting of patent protection in India
PremiumThe FlyAkari Therapeutics announces granting of patent protection in India
2M ago
AKTX
Akari Therapeutics price target raised to $7 from $4 at Alliance Global
Premium
The Fly
Akari Therapeutics price target raised to $7 from $4 at Alliance Global
3M ago
AKTX
Akari Therapeutics releases ‘Meet the Team’ video
Premium
The Fly
Akari Therapeutics releases ‘Meet the Team’ video
3M ago
AKTX
Akari Therapeutics Reports Q1 2025 Financial Results
PremiumCompany Announcements
Akari Therapeutics Reports Q1 2025 Financial Results
3M ago
AKTX
Akari Therapeutics reports Q1 EPS 0c vs 0c last year
PremiumThe Fly
Akari Therapeutics reports Q1 EPS 0c vs 0c last year
4M ago
AKTX
Akari Therapeutics appoints Kubik as Head of Business Oncology
PremiumThe Fly
Akari Therapeutics appoints Kubik as Head of Business Oncology
4M ago
AKTX
Akari Therapeutics releases video from newly appointed CEO Gaslightwala
PremiumThe Fly
Akari Therapeutics releases video from newly appointed CEO Gaslightwala
4M ago
AKTX
Akari Therapeutics Advances ADC Development Amid Financial Challenges
PremiumCompany AnnouncementsAkari Therapeutics Advances ADC Development Amid Financial Challenges
4M ago
AKTX
Akari Therapeutics reports FY24 EPS 0c vs 0c last year
Premium
The Fly
Akari Therapeutics reports FY24 EPS 0c vs 0c last year
5M ago
AKTX
Akari Therapeutics Delays Yearly Financial Report
Premium
Company Announcements
Akari Therapeutics Delays Yearly Financial Report
5M ago
AKTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >